Switch theme
Sign up to access all valuation multiples
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.
2008
27.9K+
LTM Revenue $9.1B
LTM EBITDA $431M
$4.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Welcia Holdings has a last 12-month revenue (LTM) of $9.1B and a last 12-month EBITDA of $431M.
In the most recent fiscal year, Welcia Holdings achieved revenue of $8.9B and an EBITDA of $371M.
Welcia Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Welcia Holdings valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $9.1B | XXX | $8.9B | XXX | XXX | XXX |
| Gross Profit | $2.8B | XXX | $2.7B | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $431M | XXX | $371M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| EBIT | $259M | XXX | $253M | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $123M | XXX | $104M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $27.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 2, 2025, Welcia Holdings's stock price is JPY 2522 (or $18).
Welcia Holdings has current market cap of JPY 524B (or $3.6B), and EV of JPY 570B (or $4.0B).
See Welcia Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.0B | $3.6B | XXX | XXX | XXX | XXX | $0.59 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 2, 2025, Welcia Holdings has market cap of $3.6B and EV of $4.0B.
Welcia Holdings's trades at 0.4x EV/Revenue multiple, and 10.3x EV/EBITDA.
Equity research analysts estimate Welcia Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Welcia Holdings has a P/E ratio of 29.6x.
See valuation multiples for Welcia Holdings and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.6B | XXX | $3.6B | XXX | XXX | XXX |
| EV (current) | $4.0B | XXX | $4.0B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 9.2x | XXX | 10.3x | XXX | XXX | XXX |
| EV/EBIT | 15.3x | XXX | 15.2x | XXX | XXX | XXX |
| EV/Gross Profit | 1.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 29.6x | XXX | 31.0x | XXX | XXX | XXX |
| EV/FCF | 51.4x | XXX | 16.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialWelcia Holdings's last 12 month revenue growth is 5%
Welcia Holdings's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Welcia Holdings's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Welcia Holdings's rule of X is 17% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Welcia Holdings and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 9% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 17% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Welcia Holdings acquired XXX companies to date.
Last acquisition by Welcia Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Welcia Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Welcia Holdings founded? | Welcia Holdings was founded in 2008. |
| Where is Welcia Holdings headquartered? | Welcia Holdings is headquartered in Japan. |
| How many employees does Welcia Holdings have? | As of today, Welcia Holdings has 27.9K+ employees. |
| Who is the CEO of Welcia Holdings? | Welcia Holdings's CEO is Mr. Hideaki Kirisawa. |
| Is Welcia Holdings publicy listed? | Yes, Welcia Holdings is a public company listed on TKS. |
| What is the stock symbol of Welcia Holdings? | Welcia Holdings trades under 3141 ticker. |
| When did Welcia Holdings go public? | Welcia Holdings went public in 2008. |
| Who are competitors of Welcia Holdings? | Similar companies to Welcia Holdings include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Welcia Holdings? | Welcia Holdings's current market cap is $3.6B |
| What is the current revenue of Welcia Holdings? | Welcia Holdings's last 12 months revenue is $9.1B. |
| What is the current revenue growth of Welcia Holdings? | Welcia Holdings revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Welcia Holdings? | Current revenue multiple of Welcia Holdings is 0.4x. |
| Is Welcia Holdings profitable? | Yes, Welcia Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Welcia Holdings? | Welcia Holdings's last 12 months EBITDA is $431M. |
| What is Welcia Holdings's EBITDA margin? | Welcia Holdings's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of Welcia Holdings? | Current EBITDA multiple of Welcia Holdings is 9.2x. |
| What is the current FCF of Welcia Holdings? | Welcia Holdings's last 12 months FCF is $77.1M. |
| What is Welcia Holdings's FCF margin? | Welcia Holdings's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Welcia Holdings? | Current FCF multiple of Welcia Holdings is 51.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
